South Africa is considered a clinical research “hot spot” due to its diverse genetic, drug-naive patient population, known for supplying high-quality data across all phases of …

All sub-Saharan countries, including Botswana, South Africa and Zimbabwe, face a severe HIV and AIDS epidemic. As many authors have already suggested, one solution to …

Matan Topper-Erez of TransCom Global explores the challenges raised by conducting clinical trials in Israel, an ever-popular destination for multinational clinical trials, and its unique multilingual landscape. …